A Promising Approach to Treat Psoriasis: Inhibiting Cytochrome P450 3A4 Metabolism to Enhance Desoximetasone Therapy

(1) Background: Human keratinocytes and murine skin express various cytochrome P450 enzymes. These include cytochrome P450 3A4, which may participate in the metabolism of cytochrome P450 3A4 substrate drugs. Desoximetasone, a topical corticosteroid and cytochrome P450 3A4 substrate, is used to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jiun-Wen, Cheng, Yu-Pin, Lim, Cherng-Jyr, Liu, Chih-Yi, Jee, Shiou-Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458942/
https://www.ncbi.nlm.nih.gov/pubmed/37631230
http://dx.doi.org/10.3390/pharmaceutics15082016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458942/
https://www.ncbi.nlm.nih.gov/pubmed/37631230
http://dx.doi.org/10.3390/pharmaceutics15082016

Ejemplares similares